Cargando…

The treatment of malignant glaucoma in nanophthalmos: a case report

BACKGROUND: The management of eyes with nanophthalmos is a dilemma for ophthalmologists due to various complications, especial the eye with malignant glaucoma. We report a case of effective treatment for malignant glaucoma in nanophthalmos. CASE PRESENTATION: An 82-year-old man was performed phacoem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Du, Ergang, Tang, Jinfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824548/
https://www.ncbi.nlm.nih.gov/pubmed/29471807
http://dx.doi.org/10.1186/s12886-018-0714-5
_version_ 1783302048268156928
author Wang, Jie
Du, Ergang
Tang, Jinfei
author_facet Wang, Jie
Du, Ergang
Tang, Jinfei
author_sort Wang, Jie
collection PubMed
description BACKGROUND: The management of eyes with nanophthalmos is a dilemma for ophthalmologists due to various complications, especial the eye with malignant glaucoma. We report a case of effective treatment for malignant glaucoma in nanophthalmos. CASE PRESENTATION: An 82-year-old man was performed phacoemulsification in the right eye with normal ocular pressure and nanophthalmos. The surgery was uneventful: an intraocular lens (IOL) was placed and centered in the capsular bag. 2 months later, the patient presented with malignant glaucoma, and the intraocular pressure fluctuated between 18.6 mmHg and 30.8 mmHg with antiglaucoma medications. The patient did not respond to surgical peripheral iridotomy and goniosynechialysis. Then a single treatment with laser peripheral lens posterior capsulotomy and vitreous anterior membranectomy was performed. The intraocular pressure normalized, and the anterior chamber deepened within 24 h. The patient’s condition remained stable for 9 months with no further treatment, and his Snellen corrected distance visual acuity was 20/50. The left eye of this patient was treated by combined surgery including phacoemulsification, IOL implantation, anterior vitrectomy, surgical peripheral iridotomy (PI), and goniosynechialysis. No intraoperative or postoperative complications were observed. CONCLUSIONS: This case suggests that it is essential to choose a suitable treatment for nanophthalmos patients to deal with malignant glaucoma and to reduce the incidence of malignant glaucoma.
format Online
Article
Text
id pubmed-5824548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58245482018-02-26 The treatment of malignant glaucoma in nanophthalmos: a case report Wang, Jie Du, Ergang Tang, Jinfei BMC Ophthalmol Case Report BACKGROUND: The management of eyes with nanophthalmos is a dilemma for ophthalmologists due to various complications, especial the eye with malignant glaucoma. We report a case of effective treatment for malignant glaucoma in nanophthalmos. CASE PRESENTATION: An 82-year-old man was performed phacoemulsification in the right eye with normal ocular pressure and nanophthalmos. The surgery was uneventful: an intraocular lens (IOL) was placed and centered in the capsular bag. 2 months later, the patient presented with malignant glaucoma, and the intraocular pressure fluctuated between 18.6 mmHg and 30.8 mmHg with antiglaucoma medications. The patient did not respond to surgical peripheral iridotomy and goniosynechialysis. Then a single treatment with laser peripheral lens posterior capsulotomy and vitreous anterior membranectomy was performed. The intraocular pressure normalized, and the anterior chamber deepened within 24 h. The patient’s condition remained stable for 9 months with no further treatment, and his Snellen corrected distance visual acuity was 20/50. The left eye of this patient was treated by combined surgery including phacoemulsification, IOL implantation, anterior vitrectomy, surgical peripheral iridotomy (PI), and goniosynechialysis. No intraoperative or postoperative complications were observed. CONCLUSIONS: This case suggests that it is essential to choose a suitable treatment for nanophthalmos patients to deal with malignant glaucoma and to reduce the incidence of malignant glaucoma. BioMed Central 2018-02-23 /pmc/articles/PMC5824548/ /pubmed/29471807 http://dx.doi.org/10.1186/s12886-018-0714-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Wang, Jie
Du, Ergang
Tang, Jinfei
The treatment of malignant glaucoma in nanophthalmos: a case report
title The treatment of malignant glaucoma in nanophthalmos: a case report
title_full The treatment of malignant glaucoma in nanophthalmos: a case report
title_fullStr The treatment of malignant glaucoma in nanophthalmos: a case report
title_full_unstemmed The treatment of malignant glaucoma in nanophthalmos: a case report
title_short The treatment of malignant glaucoma in nanophthalmos: a case report
title_sort treatment of malignant glaucoma in nanophthalmos: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824548/
https://www.ncbi.nlm.nih.gov/pubmed/29471807
http://dx.doi.org/10.1186/s12886-018-0714-5
work_keys_str_mv AT wangjie thetreatmentofmalignantglaucomainnanophthalmosacasereport
AT duergang thetreatmentofmalignantglaucomainnanophthalmosacasereport
AT tangjinfei thetreatmentofmalignantglaucomainnanophthalmosacasereport
AT wangjie treatmentofmalignantglaucomainnanophthalmosacasereport
AT duergang treatmentofmalignantglaucomainnanophthalmosacasereport
AT tangjinfei treatmentofmalignantglaucomainnanophthalmosacasereport